Masks are required inside all of our care facilities. We are vaccinating all eligible patients. Learn more:
Vaccines, Boosters & Additional Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus
Find more COVID-19 testing locations on Maryland.gov.
Mary Elizabeth M. Younger, Ph.D., M.A.
People with primary or secondary immunodeficiencies; immunoglobulin replacement therapy; psychosocial issues faced by people with immunodeficiencies ...read more
Dr. Mary Elizabeth Younger is an assistant professor of pediatrics at the Johns Hopkins School of Medicine.
Dr. Younger received her undergraduate degree from the University of Virginia. She earned her master’s degree from New York University and a Ph.D. from the University of Virginia.
Wasserman, R.L., Stein, M. R., Younger, M.E.M., Fatteh, S. & Haddad, E. (2016). 20% Subcutaneous immunoglobulin dosed biweekly for primary immunodeficiency. Annals of Allergy, Asthma and Immunology, 117(1), 93-94
Ballow, M., Sriaroon, P., Rachid, R., Seeborg, F., Duff, C., Bonilla, F., Younger, M. E. M., & Shapiro, R. (2017). Construction and Validation of a Disease-specific Quality of Life (HR-QOL) Instrument for Patients with Primary Antibody Deficiency Disease. Journal of Allergy and Clinical Immunology
Younger, M. E. M., Aro, L., Blouin, W., Duff, C., Epland. K. B., Murphy, E., & Sedlak, D. Nursing guidelines for administration of immunoglobulin replacement therapy. Journal of the Infusion Nurses Society 2013; 36(1), 58-68
Younger, M.E.M., Epland, K., Zampelli, A., & Hintermeyer, M.K. Identification, evaluation and management of primary immunodeficiency diseases: A review for primary care providers. The Nurse Practitioner 2015, 40(2):1-7
Younger, M. E. M., Blouin, W., Duff, C., Epland, K. B., Murphy, E., & Sedlak, D. Subcutaneous immunoglobulin replacement therapy: Ensuring success. Journal of Infusion Nursing 2015, 38(1), 70-79